BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30669160)

  • 1. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
    Rott H
    Hamostaseologie; 2019 Feb; 39(1):42-48. PubMed ID: 30669160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
    Carr BR; Ory H
    Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
    Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
    Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G; Sabbagh E; Hugon-Rodin J
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic hormonal contraception and risk of venous thromboembolism.
    Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
    BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraception, venous thrombosis and biological plausability.
    Rott H
    Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS; Kaye JA; Russmann S; Jick H
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk.
    Morimont L; Haguet H; Dogné JM; Gaspard U; Douxfils J
    Front Endocrinol (Lausanne); 2021; 12():769187. PubMed ID: 34956081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
    Schink T; Princk C; Braitmaier M; Haug U
    BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
    Shapiro S; Dinger J
    J Fam Plann Reprod Health Care; 2010 Jan; 36(1):33-8. PubMed ID: 20067670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraception in women with endometriosis: a systematic review.
    Grandi G; Barra F; Ferrero S; Sileo FG; Bertucci E; Napolitano A; Facchinetti F
    Eur J Contracept Reprod Health Care; 2019 Feb; 24(1):61-70. PubMed ID: 30664383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.